Drug
GW406381
GW406381 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_3
3
60%
Phase Distribution
2
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 33 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment
NCT00373243
completedphase_3
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
NCT00113308
completedphase_3
Dental Pain (Following Third Molar Tooth Extraction) Study
NCT00114049
completedphase_3
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
NCT00120900
completedphase_1
GW406381 In Patients With Peripheral Nerve Injury
NCT00279032
Clinical Trials (5)
Showing 5 of 5 trials
NCT00373243Phase 1
A Study Of GW406381 In Volunteers With Moderate Hepatic Impairment
NCT00113308Phase 3
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
NCT00114049Phase 3
Dental Pain (Following Third Molar Tooth Extraction) Study
NCT00120900Phase 3
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
NCT00279032Phase 1
GW406381 In Patients With Peripheral Nerve Injury
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5